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A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct
subtype of diffuse large B-cell lymphoma
Aims: Primary lymphoma of the thyroid gland (PTL) is a
relatively rare disease. During an 18-year period, 53
cases of primary non-Hodgkin's lymphoma involving
this extranodal site were seen at our institutions. The
aims of this study were to evaluate the spectrum of PTLs
using current lymphoma classi®cation concepts and
immunocytochemical markers, determine whether fea-
tures of MALT-type lymphoma were evident in PTL, and
if there was any clinical signi®cance of such a ®nding.
Methods and results: The cases were retrospectively
studied clinically, histologically and immunohisto-
chemically. The tumours were classi®ed according to
the Revised European±American Lymphoma Classi®ca-
tion of lymphoid malignancies (REAL classi®cation).
Thirty-eight patients were females, 15 were males and
mean age at diagnosis was 66.3 years (range 38±90).
Three cases were low-grade marginal zone lymphomas
(low-grade MALT-type lymphomas). There were 45
diffuse large B-cell lymphomas (DLBCL) of which there
were 27 DLBCL-NOS and 18 high-grade MALT-type
lymphomas. Within the diffuse large B-cell lymphoma
(DLBCL) category, cases were subdivided into those
without (DLBCL-NOS) and those with features of `high-
grade' MALT-type lymphoma based on presence of a
low-grade component or large cell lymphoepithelial
lesions (HG MALT-type lymphoma). In addition there
were three follicle centre lymphomas, one anaplastic
large cell lymphoma and one peripheral T-cell lym-
phoma. Twenty cases were stage IE, 18 stage IIE, and
four stage IV. All patients with low-grade MALT-type
lymphoma are alive without disease. The 5-year
survivals for DLBCL-NOS and HG MALT-type lymphoma
were 75% and 25%, respectively. Univariate analysis
(log rank) among the DLBCLs showed stage (P<0.001)
and subtype (P0.005) were associated with survival.
Stage was associated with type of DLBCL, 65% of
DLBCL-NOS being stage IE compared to 20% of HG
MALT-type lymphomas.
Conclusions: We conclude that primary thyroid lymph-
omas occur most commonly in elderly women and are
frequently present in clinical stage IE and IIE. Low-grade
MALT-type lymphomas are relatively uncommon but
appear to have a favourable prognosis. DLBCL is the
most common lymphoma and features of MALT can be
seen in over one-third of cases. As a group, HG MALT-
type lymphomas had a worse outcome than DLBCL-
NOS, primarily due to higher clinical stage at diagnosis.
These two subtypes of DLBCL appear to be distinct
clinical and histological entities.
Keywords: lymphoepithelial lesion, MALT-type lymphoma, mucosa-associated lymphoid tissue (MALT), primary
thyroid lymphoma
Introduction
Primary thyroid lymphoma (PTL) affects predominantly
elderly patients, the majority of them women over 60
years of age. The condition is rare, accounting for less
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than 5% of all thyroid malignancies1 and less than 2%
of extranodal lymphomas.2 Thus they are seen infre-
quently by most pathologists and can be confused with
a wide variety of entities, including benign disorders
such as Hashimoto's thyroiditis at one end of the
spectrum and undifferentiated carcinomas at the other
end.
In general, PTLs are most commonly high-grade
(large cell) lymphomas3±6 although occasional series
show a predominance of low-grade lymphomas.7
Relatively few large series of primary thyroid lymphoma
have been published and varying terminologies have
been used over the years. Most reports of primary
thyroid lymphoma were published prior to the publica-
tion of the REAL classi®cation and the concept of low-
grade B-cell lymphomas of mucosa-associated lymphoid
tissue (MALT) type.2±17 In the recent literature only two
studies focused on the clinical signi®cance of histolog-
ical grade and histopathological features of MALT for
prognosis of these neoplasms.18,19 One found morpho-
logical subtype did not correlate signi®cantly with
survival in a series of 50 cases.19 In the other study,
the authors analysed 45 cases and reported a favourable
prognosis for thyroid lymphomas with features of MALT
even within high-grade lymphomas.18 We report our
retrospective analysis of 53 patients with primary
malignant lymphoma of the thyroid gland using
modern histopathological classi®cation. The relation-
ship between overall survival, histological grade and the
presence or absence of MALT origin was investigated.
Materials and methods
C A S E S E L E C T I O N
The cases were retrieved from the pathology ®les of the
Cleveland Clinic Foundation, Cleveland, Ohio and
University of Michigan, Ann Arbor, Michigan. A total
of 53 cases during the 18-year period 1980±98 was
available for study (19 from the University of Michigan
and 34 from the Cleveland Clinic Foundation). Thirty-
®ve cases were diagnosed on either excisional biopsy,
subtotal or total thyroidectomy. Eighteen patients
underwent a needle biopsy. Paraf®n blocks were
available from all cases and the sections were stained
with haematoxylin and eosin.
The clinical records of the patients were analysed
with respect to symptoms, stage, treatment and
survival. Cases were included in the study when
primary symptoms and the reason for seeking medical
advice were associated with disease of the thyroid
gland.20 For clinical staging the modi®ed Ann Arbor
classi®cation was used.21,22 All of our stage IIE cases
except one would belong to the IIE1 stage according to
Musshoff (the lymph node involvement limited to
regional nodes).21 Therefore we did not use the
subclassi®cation of the stage IIE lymphomas in our
study.
C L A S S I F I C AT I O N B Y H I S T O L O G I C A L T Y P E
The lymphomas were reviewed and classi®ed according
to the REAL classi®cation.23 The type of specimen
(excision or needle biopsy) was noted. Among the
DLBCLs, cases were further subdivided into DLBCL-NOS
(where there was no evidence of MALT origin) or HG
MALT-type lymphoma. In the latter, the diagnosis was
based on presence of a low-grade MALT component or
large cell lymphoepithelial lesions (lymphoepithelial
lesions composed of large lymphoma cells).
I M M U N O H I S T O C H E M I S T RY
Formalin or B5-®xed, paraf®n-embedded tissues were
stained with the following antibodies: AE1/AE3 (cyto-
keratins, titre 1 : 300, Boehringer Mannheim, Indiana-
polis, IN), L26 (CD20, titre 1 : 500, DAKO Corporation,
Carpinteria CA), Leu22 (CD43, 1 : 200, Becton Dick-
inson, San Jose, CA), peroxidase-conjugated rabbit
polyclonal anti-kappa (1 : 80, DAKO) and peroxidase-
conjugated rabbit polyclonal anti-lambda (1 : 20,
DAKO). Two cases of follicle centre lymphoma were
also stained with CD10 (1 : 5, Novocastra Laboratories,
Newcastle, UK) and bcl-2 (neat, Ventana Medical
System, Tucson, AZ). The one case of peripheral T-cell
lymphoma was also stained with UCHL-1 (CD45RO,
1 : 50, Zymed Laboratories, San Francisco, CA). Stain-
ing was performed using an automated stainer (Ven-
tana Medical System, Tucson, AZ), with microwave
antigen retrieval for CD20, CD43, CD10 and bcl-2
(10 mM citrate, pH 6.0). The peroxidase-conjugated
antibodies were detected by incubating the deparaf®-
nized steam-pretreated tissues with the following
reagents (room temperature): 3% hydrogen peroxide/
methanol for 20 min, suppressor goat serum (1 : 20) for
10 min, primary antiserum for 1 h, and 0.4 g/l DAB
with 60 mg/l hydrogen peroxide in phosphate-buffered
saline (pH 7.15) for 10 min
Not every case was evaluable for each marker
because of a lack of suf®cient amount of tissue in the
paraf®n blocks. In two cases of DLBCL kappa and
lambda stains were not performed and in one LG MALT-
type lymphoma cytokeratin and CD43 could not be
performed. In one HG MALT-type lymphoma, eight
DLBCL-NOS and one FCL, only an immunostain for CD
20 was available.
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C L I N I C A L F O L L O W- U P
The clinical follow-up was obtained from patient records
and communication with referring physicians. The clinical
stage was based on available information in the patient
record and matched the recorded clinical stage in all cases.
S TAT I S T I C A L A NA LYS I S
Kaplan±Meier survival curves were calculated using
death from the disease as the clinical endpoint for
disease-speci®c survival. Curves were compared by the
log-rank test. The chi-square was used in univariate
analysis of nominal data. All analyses were performed
using Statistica statistic software (Statsoft, Tulsa, OK).
The follicle centre lymphomas, anaplastic large cell
lymphoma and peripheral T-cell lymphoma were not
included in the statistical analysis, since they repre-
sented only rare histological types encountered in the
thyroid gland. Also the low-grade MALT-type lymph-
omas were too few to be analysed.
A separate survival analysis of DLBCL-NOS and HG
MALT-type lymphomas was also performed after exclusion
of all cases diagnosed by needle biopsy. This was done in an
effort to reduce bias based on small tissue sample size.
Results
C L I N I C A L
Fifty-three cases of thyroid lymphomas from 38 women
and 15 men were studied (male: female ratio 1 : 2.5).
These 53 cases included three low-grade MALT-type
lymphomas, 27 DLBCL-NOS, 18 HG MALT-type lym-
phomas, three follicle centre lymphomas, one anaplastic
large cell lymphoma and one peripheral T-cell lym-
phoma. The presenting symptoms were known in 52
patients. A neck mass was observed in all 52 cases at
admission, 19 patients (37%) also complained of
dysphagia, nine (17%) had signs of tracheal compres-
sion and seven patients (13%) also presented with
hoarseness. The age of the patients ranged from 38 to
90 years (mean 66.3 years). Clinical stage of the disease
was known in 42 patients.
Patient distribution according to stage is detailed in
Table 1. For 11 patients, the stages were unknown. 20
cases were stage IE, 18 stage IIE, and four stage IV. All
low-grade MALT-type lymphomas were stage IE. Within
the high-grade MALT-type lymphoma category, three
cases (20%) were stage IE, 10 cases (67%) were stage IIE
and two (13%) were stage IV. Within the DLBCL-NOS
category, 13 cases (65%) were stage IE, 6 (30%) stage IIE
and one case (5%) was stage IV.
H I S T O PAT H O L O G Y A N D I M M U N O P H E N O T Y P I N G
Extranodal marginal zone B-cell lymphoma (low-grade
MALT-type lymphoma)
Excisional biopsies were available for review for all three
patients with low-grade MALT-type lymphomas. All
cases were characterized by a dense in®ltrate of
marginal zone cells. Cells were small-to-intermediate
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Subtype Number Stage* Number
Low-grade MALT-type lymphoma 3 IE 3
High-grade MALT-type lymphoma 18 IE 3
IIE 10
IV 2
DLBCL-NOS 27 IE 13
IIE 6
IV 1
Follicle centre lymphoma 3 IE 1
IIE 1
T-cell anaplastic large cell lymphoma 1 IIE 1
Peripheral T-cell lymphoma 1 IV 1
*Stage information not available in seven cases of DLBCL, three cases of high-grade MALT
lymphoma and one case of follicle centre lymphoma.
Table 1. Summary of stages
in size with irregular (but not cleaved) nuclei and clear
cytoplasm. Scattered larger cells were occasionally
present. Large lymphoepithelial lesions (LELs) distended
and `stuffed' with marginal zone cells were present in all
cases (Figure 1). Lymphocytic thyroiditis was seen in
adjacent thyroid tissue in all three cases.
Immunohistochemistry showed CD20 expression on
neoplastic cells, including those within LELs, in all
cases. All three cases contained polytypic plasma cells.
Diffuse large B-cell lymphomaÐhigh-grade MALT-type
lymphoma
Sixteen patients were found to have diffuse large B-cell
lymphoma without a recognizable low-grade component
and were classi®ed as high-grade MALT-type lymphomas
by virtue of LELs composed of large cells. These cells had
vesicular chromatin and multiple small nucleoli resem-
bling centroblasts (Figure 2a). Eight cases showed
lymphocytic thyroiditis in adjacent thyroid tissue. All
specimens available were excisional biopsies. All cases
expressed CD20 in neoplastic cells. CD43 coexpression
was seen in three cases. No light chain restriction was seen
in plasma cells. Cytokeratin stain highlighted the
lymphoepithelial lesions (Figure 2b). In one case, due to
the lack of tissue, only a CD20 immunostain was available.
Two cases showed large cell lymphoma in a back-
ground of low-grade MALT-type lymphoma. The low-
grade component was recognized by small areas with a
diffuse in®ltrate of marginal zone cells and the presence
of low-grade LELs composed of small lymphocytes. Both
cases showed lymphocytic thyroiditis in adjacent
thyroid tissue. Tissue available for review was from
excisional biopsies in both cases. Neoplastic cells in both
cases expressed CD20, whereas coexpression of CD43
was seen in one case. Kappa light chain restriction in
plasma cells was seen in both cases.
Diffuse large B-cell lymphoma ÿ NOS
Twenty-seven cases were classi®ed in this group, where
no features of MALT-type lymphoma were seen.
Cytologically, these lymphomas were composed predo-
minantly of large, centroblastic cells arranged in sheets,
replacing the thyroid follicles without forming any LELs
(Figure 3). Lymphocytic thyroiditis was seen in ®ve
cases, however, in 15 cases of this group little or no
residual thyroid tissue was available for review.
Excisional biopsies were available from 11 patients
and needle biopsies from 16 patients.
Immunohistochemistry showed CD20 expression in
all cases and CD43 coexpression in one case. No light
chain restriction was seen by paraf®n immunohisto-
chemistry. The cytokeratin stain con®rmed the absence
of LELs. In 8 cases, due to the lack of tissue, only a CD20
stain was available.
Follicle centre lymphomas
Three patients were found to have classic architecture of
a follicle centre lymphoma, with uniform nodularity
and little variation in size and shape of the follicles, a
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Figure 1. Low-grade MALT-type lymphoma. Lymphoepithelial
lesions are distended and ®lled with marginal zone cells.
Figure 2. a, High-grade MALT-type lymphoma. Lymphoepithelial
lesions are composed of large cells with vesicular chromatin and
small nucleoli. b, High-grade MALT-type lymphoma. Cytokeratin
stain highlights the lymphoepithelial lesions ®lled with large cells.
back-to-back arrangement of follicles, lack of cellular
polarization and absence of tingible body macrophages.
All three cases were classi®ed as provisional grade 2
follicle centre lymphomas (mixed, small cleaved and
large cell). Evidence of lymphocytic thyroiditis was seen
in one case. Two specimens were excisional biopsies and
one was a needle biopsy.
Neoplastic cells stained with CD20 in all three cases,
CD10 and bcl-2 in two cases where there was
tissue available for immunostaining, and one of these
showed kappa light chain restriction by paraf®n
immunohistochemistry. In one case, due to the lack of
tissue, only a CD20 stain was available.
Anaplastic large cell lymphoma
One case was classi®ed as anaplastic large cell
lymphoma, characterized by a proliferation of large
lymphoma cells with bizarre, anaplastic cytologic
features. An excisional biopsy was available from this
patient. The tumour cells expressed CD43, were
negative for CD20, and showed membranous and
Golgi immunostaining with anti-CD30.
Peripheral T-cell lymphoma
In one case a diagnosis of peripheral T-cell lymphoma,
unspeci®ed was made based on a relatively homogenous
population of small cells with irregularly shaped nuclei,
diffusely replacing the thyroid architecture. A needle
biopsy was available in this case. The neoplastic cells
expressed CD43 and CD45RO but were negative for
CD20.
Clinical outcome
Treatment information was available for 42 patients.
Therapeutic approaches included: radiotherapy alone
(11 patients); chemotherapy alone (12 patients);
chemotherapy and radiotherapy (13 patients); surgery,
chemotherapy and radiotherapy (three patients); sur-
gery and radiotherapy (two patients); and surgery and
chemotherapy (one patient).
Clinical follow-up was available for 45 patients; the
mean follow-up was 46.5 months (range 1±151 months).
Overall, 14 patients died of disease, four were alive with
disease, and 27 were alive without evidence of disease.
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Figure 3. Diffuse large cell lymphoma, NOS. Large, centroblastic
cells arranged in sheets replace the follicles without forming any
lymphoepithelial lesions.
Subtype Number Patient status* Number
Low-grade MALT-type lymphoma 3 ANED 3
High-grade MALT-type lymphoma 18 ANED 7
AWD 1
DOD 8
DLBCL-NOS 27 ANED 16
AWD 2
DOD 4
Follicle centre lymphoma 3 ANED 1
AWD 1
T-cell anaplastic large cell lymphoma 1 DOD 1
Peripheral T-cell lymphoma 1 DOD 1
ANED, alive, no evidence of disease; AWD, alive with disease; DOD, dead of disease.
* Patient status unknown in ®ve cases of DLBCL, two cases of high-grade MALT-type
lymphoma and one case of follicle centre lymphoma.
Table 2. Summary of clinical
outcome
All patients with low-grade MALT-type lymphoma
were alive without disease at a mean of 26 months.
Eight patients (53%) with high-grade MALT-type
lymphoma died of disease at a mean of nine months
from diagnosis. Four patients (20%) with DLBCL-NOS
died of disease at a mean of 30 months from diagnosis.
Clinical follow-up was available in two patients with
follicle centre lymphoma. None of them died of disease
at a mean of 121 months. The patient with anaplastic
large cell lymphoma died of disease at 41 months after
diagnosis. The patient with peripheral T-cell lymphoma
died of disease one month after diagnosis (see Table 2 for
a summary of clinical outcome).
The ®ve-year survivals for DLBCL-NOS and high-
grade MALT-type lymphomas were 75% and 25%,
respectively. Among the DLBCLs, Kaplan-Meier curves
and log rank analysis showed that clinical stage and
histological subtype were highly signi®cant factors in
disease-speci®c survival (P<0.001 and P0.005,
respectively; Figures 4 and 5). Stage was associated
with histological type, 65% of DLBCL-NOS being stage IE
compared to 20% of high-grade MALT-type lympho-
mas. Age of the patient at the time of diagnosis (lower
vs. higher than 65 years) was not signi®cantly
associated with survival on univariate analysis.
Diagnosis of all low and high-grade MALT-type
lymphomas was based on examination of excisional
biopsy or thyroidectomy specimens. Eleven cases of
DLBCL-NOS (41%) were diagnosed on excisional biopsy
or thyroidectomy specimens; in the remaining 16 cases
(59%) a needle biopsy was available. To eliminate a
potential in¯uence of the type of specimen on our
®ndings, we performed separate survival analysis
limited to excisional biopsies and thyroidectomy speci-
mens. This analysis con®rmed the signi®cance of both
subtype (P0.029) and stage of the disease (P0.02)
for survival.
As listed above, the mode of therapy varied among
cases due to the retrospective nature of the study
spanning 20 years. We attempted to analyse the impact
of different therapeutic regimens on outcome of high-
stage patients (stages II±IV) grouped by radiotherapy
alone, chemotherapy alone and chemotherapy with
radiotherapy. However, we did not ®nd any signi®cant
difference in survival (log rank: P0.3).
Discussion
The concept of lymphomas of mucosa-associated
lymphoid tissue has been extensively described in
gastric lymphomas and has been extended to extranodal
lymphomas at many sites, including the thyroid. MALT-
type lymphomas can undergo transformation to large
cell (high-grade) lymphoma and several studies have
recognized the features of MALT in large cell lymph-
omas at MALT sites, most commonly in the stomach.24±
27 These studies showed that between 17% and 68% of
all gastric lymphomas had features of a high-grade
MALT-type lymphoma (presence of LELs or a low-grade
component). It appears that the presence of a high-
grade component in the stomach has prognostic
signi®cance.28 In contrast to the stomach, there have
been very few studies of primary thyroid lymphoma
focusing on the presence of histopathological features of
MALT, since most series were published prior to the
widespread recognition of the histopathological features
of MALT.
We retrospectively reviewed a series of 53 primary
lymphomas of the thyroid gland, using modern
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Figure 4. Survival by stage (stage IE vs. stages IIE±IV).
Figure 5. Survival by diagnosis (DLBCL-NOS vs. HG MALT-type
lymphoma).
lymphoma classi®cation criteria, to determine their
histological spectrum and investigating the signi®cance
of MALT features, particularly in high-grade (large cell)
lymphomas. The majority (45 of 53, or 85%) of cases of
primary thyroid lymphomas in our series were diffuse
large B-cell lymphomas. This is in agreement with a
number of previous studies.4,6,12,16,19 In addition, we
found features of MALT-type lymphoma in 18 of 45
(40%) of DLBCLs. In two cases there was evidence of a
concurrent low-grade MALT-type component in the
background. In the remaining cases there was no
recognizable low-grade component, but lymphoepithe-
lial lesions composed of large lymphoma cells were
noted (high-grade LELs). Because LELs are one of the
hallmarks of MALT-type lymphomas,6,29 we classi®ed
these large-cell lymphomas as high-grade MALT
lymphomas. In 27 of 45 (60%) DLBCLs, no features of
MALT were identi®ed. These cases were classi®ed as
DLBCL-NOS. In addition to the DLBCL-NOS and MALT-
type lymphomas of thyroid, we encountered three other
types of lymphoma primary to the thyroid gland,
including follicle centre lymphoma (6%), T-cell ana-
plastic large cell lymphoma (2%) and peripheral T-cell
lymphoma (2%). The percentage of follicle lymphomas
is signi®cantly lower than in some earlier series, but
many MALT-type lymphomas may have been previously
diagnosed as follicle centre lymphomas.29,30 Since most
of our cases (85%) were diffuse large B-cell lymphomas,
we focused our analysis on this category with the aim to
ascertain potential differences in clinical behaviour of
DLBCL-NOS and high-grade MALT-type lymphoma. We
found that the overall 5-year survivals differed sig-
ni®cantly between these two groups (75% vs. 25%). The
histological subtype and clinical stage were associated
with survival on univariate analysis (P0.005 and
P <0.001, respectively). Given the close relationship
between the subtype and clinical stage, the survival
advantage of DLBCL-NOS was likely to be stage related
(65% of DLBCL-NOS were stage IE compared to 20% of
high-grade MALT-type lymphomas).
It is dif®cult to place the results of our study in the
context of previous studies because of different classi-
®cations and criteria for diagnosis.4,5,7,12,15,17,29 From
a histological standpoint, we demonstrated that there
are high-grade MALT-type lymphomas, which are
distinct from DLBCL-NOS, based on the presence of
high-grade LELs or presence of low-grade MALT-type
lymphoma in the background. From a clinical stand-
point, a general conclusion can be made from the
current and previous studies that clinical stage is very
important in predicting survival.3±5,7,16,19 It appears
that even stage IIE disease is signi®cantly worse than
disease limited to the thyroid.4,5,7,16
There is less consensus about the prognostic value of
histological grade. Only two other studies incorporating
the MALT-type category of PTL published survival
data.18,19 Pedersen reported that histological grade
was not a statistically signi®cant factor in survival,
although high stage (IIIE-IV) was signi®cant.
19 In
contrast, Laing et al. found that the presence of
histopathological features of MALT was a statistically
signi®cant factor in patient survival.18 They also found
that among high-grade lymphomas, presence of a
MALT component was a favourable prognostic factor.
The authors did not directly assess the effect of low-
grade histology since they combined both high- and
low-grade grade lymphomas into their MALT category.
Interestingly, in contrast to most series, they found that
stage was not a signi®cant prognostic factor. In the older
literature, major studies from Aozosa et al.3 and
Compagno et al.5 found that histological grade was a
sign®cant factor in survival. Of note, Compagno
speci®cally stated that patients with `plasmacytomas'
were signi®cantly more likely to be disease-free as
compared to all other types.5 It is likely that these cases
of `plasmacytomas' were low-grade MALT-type lym-
phomas with plasmacytoid differentiation.31 Clinical
follow-up showed that all three patients in our study
with low-grade MALT-type lymphoma were alive with-
out disease, suggesting a favourable clinical behaviour.
Similar results were reported in the study of Hyjek et al.
in which none of three patients with follow-up died of
lymphoma.6 The small number of cases in our series
was not suf®cient for meaningful analysis. Since there
are very few reported cases of low-grade MALT-type
lymphoma of thyroid, larger long-term follow-up studies
are required. However, we suspect that localized low-
grade MALT-type lymphomas of thyroid have an
excellent prognosis as appears to be the case in other
extranodal sites.
Overall, DLBCL-NOS presented in lower stage and
showed a signi®cantly longer survival as compared to
the high-grade MALT-type lymphomas on univariate
analysis. The association between histological subtype
of DLBCL and stage was very strong and the shorter
survival of HG MALT-type lymphoma is likely stage
related. One may speculate that DLBCL-NOS, as a de
novo neoplasm, is likely to come to attention sooner
than a slower growing MALT-type lymphoma starting
as a low-grade lymphoma and undergoing subsequent
transformation to a high-grade tumour. Consequently,
DLBCL-NOS might be a more easily palpable, targeted
mass that lends itself to needle biopsy. Perhaps most
high-grade MALT-type lymphomas arise from low-
grade MALT-type lymphoma pre-existing for a long
time (subclinically) that becomes higher stage prior to
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transforming to a large cell lymphoma. Although we did
not note this feature in our cases, Hyjek et al. reported
that eight of 10 of their high-grade primary thyroid
lymphomas contained centrocyte-like cells.6 In addi-
tion, d'Amore and colleagues noted in their series of
463 extranodal lymphomas that disseminated disease
was signi®cantly associated with a low-grade histology,
suggesting that low-grade extranodal lymphomas may
indeed become higher stage prior to transformation.32
Assignment of an individual case into this category
appeared to be affected by the specimen type because all
high-grade MALT-type lymphomas were diagnosed on
excisional specimens. In order to eliminate the in¯uence
of the type of the specimen on our ®ndings we performed
a separate analysis after exclusion of all needle biopsy
specimens. This survival analysis limited to excisional
biopsies and thyroidectomy specimens con®rmed the
signi®cance of both the subtype (DLBCL-NOS vs. HG
MALT-type lymphoma) and the clinical stage (stage IE
vs. stages IIE±IV) for survival.
In summary, we report a retrospective study of
primary thyroid lymphomas that have been clinically,
histopathologically and immunophenotypically charac-
terized and reclassi®ed according to the presence or
absence of features of MALT. These lymphomas occur
most often in older women. DLBCL was by far the most
common type of lymphoma encountered at this site.
Low-grade MALT-type lymphoma is relatively uncom-
mon and in our limited follow-up appears to have a good
prognosis. High-grade MALT-type lymphomas could
frequently be identi®ed based on presence of a low-grade
component or high-grade LELs. Among DLBCL, subtype
and clinical stage were the only statistically signi®cant
prognostic factors on univariate analysis. The presence
of MALT features in DLBCL was associated with higher
stage at presentation, a ®nding that remains to be
explained as more knowledge is gained about the
pathogenesis of this lymphoma. At issue is whether
DLBCL is a single entity. Recently, Chan et al. found
evidence of trisomy 12 in DLBCL-NOS more often than
in HG MALT-type lymphoma supporting a true differ-
ence between these lymphomas at the molecular
level.33 In a recent report, Hoeve and collegues found
a higher incidence of trisomies 12 and 18 in HG MALT-
type lymphomas as opposed to large cell lymphoma of
the stomach (64% vs. 20%, respectively).34 Although
somewhat contrary to the study by Chan et al. their
®ndings also support the contention that HG MALT-type
lymphomas may be different than de novo large cell
lymphomas. Our data support the concept that DLBCL
of the thyroid is heterogeneous, with high-grade MALT-
type lymphoma, as we have de®ned it, being separable
from DLBCL-NOS. Additional studies are required to
further investigate the genetic abberations associated
with high-grade MALT-type lymphomas and DLBCL-
NOS to resolve this issue.
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